The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

safer HVAC chemicals
Stronger Training Pipelines and Smarter Social Media Can Help Solve HVAC’s Talent Shortage
June 9, 2026

The skilled trades are at a crossroads. By some industry estimates, for every five experienced technicians retiring, only two new ones are entering the field—highlighting a growing HVAC talent gap. At the same time, buildings are becoming more complex, more connected, and more dependent on high-performance mechanical systems. The stakes are real: without a…

Read More
design
Where Design Meets Durability: Why Commercial Surfaces Must Support Safety, Cleanability, and Long-Term Value
June 8, 2026

When a commercial space fails, it often fails quietly: a lobby floor that becomes slippery when wet, a hotel bathroom that is difficult to clean, a healthcare surface that cannot withstand constant disinfection, or an office finish that looks great until afternoon glare makes the room uncomfortable. These are not purely aesthetic problems; they are…

Read More
creative career
Crafted Journey How To: Building a Creative Career Across Scripts, Stages, and Sound
June 8, 2026

Creative careers rarely move in a straight line, especially for writers working across stage, screen, audio, books, and independent film. Sustaining that kind of life often means finding opportunities wherever they appear, building a strong network, staying open to different formats, and saying yes to collaborations that can lead somewhere unexpected. The stakes are…

Read More
EMR
EMR Strategy, Consulting, and Career Pivots with MedSys Co-Founder Mark Embry
June 8, 2026

Electronic medical records (EMRs) have moved from a back-office upgrade to a frontline determinant of care quality, clinician burnout, and hospital economics. With U.S. hospitals often spending tens to hundreds of millions—sometimes exceeding $100 million—on EMR implementations, the stakes have never been higher for getting both the technology and the human adoption right. As…

Read More